146 related articles for article (PubMed ID: 23873707)
1. Adjusting for reporting delay in cancer incidence when combining different sets of cancer registries.
Huang L; Midthune D; Krapcho M; Zou Z; Horner MJ; Feuer EJ
Biom J; 2013 Sep; 55(5):755-70. PubMed ID: 23873707
[TBL] [Abstract][Full Text] [Related]
2. Pilot test for linking population-based cancer registries with CCG/POG pediatric registries.
Ross F
J Ky Med Assoc; 2002 May; 100(5):195-9. PubMed ID: 12040910
[TBL] [Abstract][Full Text] [Related]
3. Trends in reporting delay in United States central cancer registries.
Boscoe FP
J Registry Manag; 2014; 41(3):135-8. PubMed ID: 25419607
[TBL] [Abstract][Full Text] [Related]
4. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.
Edwards BK; Brown ML; Wingo PA; Howe HL; Ward E; Ries LA; Schrag D; Jamison PM; Jemal A; Wu XC; Friedman C; Harlan L; Warren J; Anderson RN; Pickle LW
J Natl Cancer Inst; 2005 Oct; 97(19):1407-27. PubMed ID: 16204691
[TBL] [Abstract][Full Text] [Related]
5. Surveillance for cancers associated with tobacco use--United States, 1999-2004.
Stewart SL; Cardinez CJ; Richardson LC; Norman L; Kaufmann R; Pechacek TF; Thompson TD; Weir HK; Sabatino SA;
MMWR Surveill Summ; 2008 Sep; 57(8):1-33. PubMed ID: 18772853
[TBL] [Abstract][Full Text] [Related]
6. Melanoma surveillance in the United States: overview of methods.
Watson M; Johnson CJ; Chen VW; Thomas CC; Weir HK; Sherman R; Cockburn M; Jackson-Thompson J; Saraiya M
J Am Acad Dermatol; 2011 Nov; 65(5 Suppl 1):S6-16. PubMed ID: 22018069
[TBL] [Abstract][Full Text] [Related]
7. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
8. Colorectal cancer incidence in the United States, 1999-2004 : an updated analysis of data from the National Program of Cancer Registries and the Surveillance, Epidemiology, and End Results Program.
Rim SH; Seeff L; Ahmed F; King JB; Coughlin SS
Cancer; 2009 May; 115(9):1967-76. PubMed ID: 19235249
[TBL] [Abstract][Full Text] [Related]
9. Decline in breast cancer incidence--United States, 1999-2003.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Jun; 56(22):549-53. PubMed ID: 17557070
[TBL] [Abstract][Full Text] [Related]
10. Frequency and determinants of missing data in clinical and prognostic variables recently added to SEER.
Kim HM; Goodman M; Kim BI; Ward KC
J Registry Manag; 2011; 38(3):120-31. PubMed ID: 22223054
[TBL] [Abstract][Full Text] [Related]
11. Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival.
Jemal A; Clegg LX; Ward E; Ries LA; Wu X; Jamison PM; Wingo PA; Howe HL; Anderson RN; Edwards BK
Cancer; 2004 Jul; 101(1):3-27. PubMed ID: 15221985
[TBL] [Abstract][Full Text] [Related]
12. Factors associated with time to availability for cases reported to population-based cancer registries.
Smith-Gagen J; Cress RD; Drake CM; Felter MC; Beaumont JJ
Cancer Causes Control; 2005 May; 16(4):449-54. PubMed ID: 15953987
[TBL] [Abstract][Full Text] [Related]
13. Cancer incidence and mortality in France over the period 1978-2000.
Remontet L; Estève J; Bouvier AM; Grosclaude P; Launoy G; Menegoz F; Exbrayat C; Tretare B; Carli PM; Guizard AV; Troussard X; Bercelli P; Colonna M; Halna JM; Hedelin G; Macé-Lesec'h J; Peng J; Buemi A; Velten M; Jougla E; Arveux P; Le Bodic L; Michel E; Sauvage M; Schvartz C; Faivre J
Rev Epidemiol Sante Publique; 2003 Feb; 51(1 Pt 1):3-30. PubMed ID: 12684578
[TBL] [Abstract][Full Text] [Related]
14. Secular changes in colorectal cancer incidence by subsite, stage at diagnosis, and race/ethnicity, 1992-2001.
Cress RD; Morris C; Ellison GL; Goodman MT
Cancer; 2006 Sep; 107(5 Suppl):1142-52. PubMed ID: 16835912
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
16. Ovarian cancer incidence in the United States, 1992-1999.
Quirk JT; Natarajan N
Gynecol Oncol; 2005 May; 97(2):519-23. PubMed ID: 15863154
[TBL] [Abstract][Full Text] [Related]
17. Obtaining data on comorbid diabetes among patients in a U.S. population-based tumor registry.
Polednak AP; Phillips CE
J Registry Manag; 2010; 37(2):57-64. PubMed ID: 21086823
[TBL] [Abstract][Full Text] [Related]
18. Persistent socioeconomic inequalities in cancer survival in the United States: 1973-2007 surveillance, epidemiology and end results (SEER) data for breast cancer and non-Hodgkin's lymphoma.
Kato I; Booza J; Quarshie WO; Schwartz K
J Registry Manag; 2012; 39(4):158-66. PubMed ID: 23493021
[TBL] [Abstract][Full Text] [Related]
19. Population based analysis of the increasing incidence of kidney cancer in the United States: evaluation of age specific trends from 1975 to 2006.
Nepple KG; Yang L; Grubb RL; Strope SA
J Urol; 2012 Jan; 187(1):32-8. PubMed ID: 22088338
[TBL] [Abstract][Full Text] [Related]
20. Early estimates of SEER cancer incidence for 2012: Approaches, opportunities, and cautions for obtaining preliminary estimates of cancer incidence.
Lewis DR; Chen HS; Midthune DN; Cronin KA; Krapcho MF; Feuer EJ
Cancer; 2015 Jun; 121(12):2053-62. PubMed ID: 25739953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
